Advertisement

CancerLinQ® Partners With Leading Global Life Sciences Nonprofit


Advertisement
Get Permission

CANCERLINQ LLC and DIA (Drug Information Association), a global nonprofit association of health-care product development professionals, recently announced that they have entered into a programmatic partnership. Under the agreement, DIA will offer the scientific expertise of its members from the life sciences industry to help inform CancerLinQ’s development and rollout. CancerLinQ® is ASCO’s health information technology platform, developed by oncologists for oncologists, aimed at enhancing and improving the understanding and treatment of cancer. 

DIA Associate Director for Scientific Collaborations Tshaka Cunningham, PhD, will serve as DIA representative on the CancerLinQ® Oncology Leadership Council, the strategic advisory body comprising all official partner organizations that guides the growth and direction of CancerLinQ. DIA will have the ability to access CancerLinQ Discovery—which provides access to curated sets of statistically deidentified clinical data from the CancerLinQ® platform—for the association’s internal learning and analysis about the current, real-world state of cancer care. 

The collaboration with DIA is one of many that CancerLinQ LLC has entered into with a coalition of partners and thought leaders, including government agencies, medical specialty societies, and life sciences companies. Since 2016, the American Academy of PAs; the American Society of Radiation Oncology; Cancer Informatics for Cancer Centers; the College of American Pathologists; the U.S. Food and Drug Administration; the Hematology/Oncology Pharmacy Association; the National Cancer Institute; the Oncology Nursing Society; and the Society of Gynecologic Oncology have joined forces with CancerLinQ LLC. Additionally, in November 2016, AstraZeneca became a founding enterprise partner with CancerLinQ Discovery. These partnerships offer the CancerLinQ® team guidance and insights that ultimately can contribute to the quality and efficiency of the cancer care delivery system. 

CancerLinQ® and CancerLinQ Discoveryare projects of CancerLinQ LLC. For more information on how to participate or partner with CancerLinQ, please visit CancerLinQ.org. ■

© 2018. American Society of Clinical Oncology. All rights reserved. 


Advertisement

Advertisement



;
Advertisement